Search Results 1261-1270 of 17740 for Coma

  1. Transient ischemic attack (TIA) - Doctors and departments - Mayo Clinic

    This short bout of stroke-like symptoms doesn't cause permanent damage. But it may serve as a warning sign of a future stroke.

  2. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Mayo Clinic experts trained in sleep medicine study new diagnosis and treatment options for obstructive sleep apnea, sleep-disordered breathing and other sleep ...

  3. Glioma - Doctors and departments - Mayo Clinic

    Gliomas are the most common brain tumors in adults. Learn more about diagnosis and treatment, including innovative research to find new therapies.

  4. Sleep disorders - Doctors and departments - Mayo Clinic

    Research. Mayo Clinic sleep medicine specialists include doctors trained in lung and breathing conditions (pulmonologists), mental health conditions ...

  5. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  6. Transient ischemic attack (TIA) - Doctors and departments - Mayo Clinic

    This short bout of stroke-like symptoms doesn't cause permanent damage. But it may serve as a warning sign of a future stroke.

  7. Transient ischemic attack (TIA) - Doctors and departments - Mayo Clinic

    This short bout of stroke-like symptoms doesn't cause permanent damage. But it may serve as a warning sign of a future stroke.

  8. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Learn the signs that point to this common and potentially serious sleep disorder. And find out the treatments that can help you sleep better.

  9. Transient ischemic attack (TIA) - Doctors and departments - Mayo Clinic

    This short bout of stroke-like symptoms doesn't cause permanent damage. But it may serve as a warning sign of a future stroke.

  10. A Study Of Tolododekin Alfa (ANK-101) In Combination With An Anti-PD-1/PD-L1 Antibody In Participants With Advanced Non-Small Cell Lung Cancer - Mayo Clinic

    A study of tolododekin alfa (also known as ANK-101) administered in combination with an anti-programmed cell death protein 1 (PD-1)/programmed cell death ligand ...